1.Intra-Arterial Thrombolysis to Improve Final Thrombolysis in Cerebral Infarction Score after Thrombectomy: A Case-Series Analysis
Antonio De MASE ; Paolo CANDELARESI ; Emanuele SPINA ; Flavio GIORDANO ; Stefano BARBATO ; Giovanna SERVILLO ; Elio PRESTIPINO ; Alessandra FASOLINO ; Gianluigi GUARNIERI ; Giuseppe LEONE ; Massimo MUTO ; Mario MUTO ; Vincenzo ANDREONE
Neurointervention 2023;18(2):123-128
Endovascular thrombectomy is the standard treatment in selected patients with acute ischemic stroke and large vessel occlusion, but continuous improvement in angiographic and clinical outcome is still needed. Intra-arterial thrombolysis has been tested as a possible rescue tool in unsuccessful thrombectomy, or as an adjuvant therapy after the endovascular procedure, to pursue complete recanalization. Here we present a case series analysis of intra-arterial alteplase administration (5 mg bolus, repeated up to 15 mg if Thrombolysis in Cerebral Infarction (TICI) scale ≥2c is not achieved) in 15 consecutive anterior circulation stroke patients after unsuccessful thrombectomy, defined as TICI score ≤2b after at least 3 passes or if unsuitable for further endovascular attempts, with the aim of improving recanalization. An improvement of final TICI score was achieved in 10 of 15 patients (66.7%). TICI score ≥2c was achieved after 5 mg intra-arterial tissue plasminogen activator (iaTPA) in 4 patients, and after 10 mg iaTPA in 5 cases. Six of 15 patients received 15 mg iaTPA: 1 of 6 showed angiographical improvement. A major effect of intra-arterial alteplase was observed for distally migrated emboli. None of the patients experienced any symptomatic hemorrhagic transformation or other major bleeding. Our report shows, in a very small cohort, a high rate of final TICI score improvement, encouraging the development of randomized controlled trials of rescue intra-arterial thrombolysis in patients with suboptimal angiographic results after mechanical thrombectomy.
2.Aortopulmonary Fistula Presenting without an Endoleak after Thoracic Endovascular Aortic Repair.
Giacomo SICA ; Gaetano REA ; Giorgio BOCCHINI ; Romilda LOMBARDI ; Massimo MUTO ; Tullio VALENTE
The Korean Journal of Thoracic and Cardiovascular Surgery 2017;50(4):287-290
Herein, we report the case of a 60-year-old man, a smoker with a history of arterial hypertension and diabetes mellitus. After computed tomography (CT) for an episode of hemoptysis, the patient underwent elective thoracic endovascular aortic repair (TEVAR) because of a degenerative aneurysm of the descending thoracic aorta. The area of perianeurysmal pulmonary atelectasis reported on the CT scan was not considered. Three months later, he developed an aortopulmonary fistula without endoleaks. Although TEVAR is a relatively safe procedure, no detail should be overlooked in the preoperative evaluation in order to avoid life-threatening complications. Further, the effectiveness and modality of prolonged antibiotic prophylaxis and/or preoperative respiratory physiotherapy should be assessed in such cases.
Aneurysm
;
Antibiotic Prophylaxis
;
Aorta, Thoracic
;
Aortic Aneurysm
;
Diabetes Mellitus
;
Endoleak*
;
Endovascular Procedures
;
Fistula*
;
Hemoptysis
;
Humans
;
Hypertension
;
Middle Aged
;
Pulmonary Atelectasis
;
Tomography, X-Ray Computed
3.First Multi-Detector Computed Tomography Evidence of Transcatheter Pacing System Migration and Embolization into the Pulmonary Vasculature
Tullio VALENTE ; Giorgio BOCCHINI ; Maurizio Cappelli BIGAZZI ; Massimo MUTO ; Paolo GOLINO ; Giacomo SICA
The Korean Journal of Thoracic and Cardiovascular Surgery 2020;53(5):310-312
Transcatheter leadless pacemaker dislodgment is a rare and potentially fatal complication of leadless device implantation. We present the first case of multidetector computed tomography images of leadless pacemaker migration and embolization in the pulmonary middle lobe artery. The patient was managed by percutaneous retrieval of the dislodged device and re-implantation in the appropriate position.
4.Initial Experience Using the New pHLO 0.072-inch Large-Bore Catheter for Direct Aspiration Thrombectomy in Acute Ischemic Stroke
Giuseppe LEONE ; Massimo MUTO ; Flavio GIORDANO ; Gianluigi GUARNIERI ; Antonio Di DONNA ; Camilla RUSSO ; Daniele Giuseppe ROMANO ; Paolo CANDELARESI ; Giovanna SERVILLO ; Emanuele SPINA ; Antonio De MASE ; Vincenzo ANDREONE ; Mario MUTO
Neurointervention 2023;18(1):30-37
Purpose:
A direct aspiration, first pass technique (ADAPT) has been introduced as a rapid and safe thrombectomy strategy in patients with intracranial large vessel occlusion (LVO). The aim of the study is to determine the technical feasibility, safety, and functional outcome of ADAPT using the newly released large bore pHLO 0.072-inch aspiration catheter (AC; Phenox).
Materials and Methods:
We performed a retrospective analysis of data collected prospectively (October 2019–November 2021) from 2 comprehensive stroke centers. Accessibility of the thrombus, vascular recanalization, time to recanalization, and procedure-related complications were evaluated. National Institutes of Health stroke scale scores at presentation and discharge and the modified Rankin scale (mRS) score at 90 days post-procedure were recorded.
Results:
Twenty-five patients (14 female, 11 male) with occlusions of the anterior circulation were treated. In 84% of cases, ADAPT led to successful recanalization with a median procedure time of 28 minutes. In the remaining cases, successful recanalization required (to a total of 96%; modified thrombolysis in cerebral infarction score 2b/3) the use of stent retrievers. No AC-related complications were reported. Other complications included distal migration of the thrombus, requiring a stent-retriever, and symptomatic PH2 hemorrhage in 16% and 4%, respectively. After 3 months, 52% of the patients had mRS scores of 0–2 with an overall mortality rate of 20%.
Conclusion
Results from our retrospective case series revealed that thrombectomy of LVOs with pHLO AC is safe and effective in cases of large-vessel ischemic stroke. Rates of complete or near-complete recanalization after the first pass with this method might be used as a new benchmark in future trials.